Myriad Genetics, Inc.

Myriad Genetics Inc. is a biotechnology company specializing in the development and commercialization of genetic tests that assess risk for cancer and other hereditary conditions. The company is renowned for its pioneering efforts in molecular diagnostics, offering tests that help individuals and healthcare providers make informed decisions about disease prevention and treatment. Myriad Genetics plays a critical role in the healthcare and medical research sectors by advancing personalized medicine and facilitating the understanding of genetic contributions to disease. Their testing portfolio includes products that identify genetic markers, providing insights into the likelihood of developing various cancers, such as breast and ovarian cancer, among other conditions. Myriad’s work supports oncologists, genetic counselors, and researchers by delivering highly reliable genetic insights crucial for patient care planning. Headquartered in Salt Lake City, Utah, Myriad Genetics continues to be at the forefront of genetic testing—driving innovation that enhances predictive medicine and impacts clinical decision-making.